Overall, these data reveal that EPA reduces p-STAT3/HPS expression and ACC-1-mediated FA metabolism to inhibit the viability of SUIT-2 pancreatic cancer cells. The gene discussed is FGL1; the disease is familial pancreatic carcinoma.